Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-070806
Filing Date
2024-08-19
Accepted
2024-08-19 17:29:20
Documents
4
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0211019-10q_bioess.htm 10-Q 427410
2 CERTIFICATION ea021101901ex31-1_bioess.htm EX-31.1 22785
3 CERTIFICATION ea021101901ex32-1_bioess.htm EX-32.1 12639
4 GRAPHIC image_001.jpg GRAPHIC 7168
  Complete submission text file 0001213900-24-070806.txt   473856
Mailing Address 12 CHRYSLER UNIT B IRVINE CA 92618
Business Address 12 CHRYSLER UNIT B IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

EIN.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 241221914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)